BENITEC BIOPHARMA INC.
3940 Trust Way
Hayward, California 94545
August 3, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-1004
Attention: Jason Drory
| Re: | Benitec Biopharma Inc. |
Registration Statement on Form S-1, as amended
File No. 333-273177
Dear Mr. Drory:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Benitec Biopharma Inc. hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-273177), as amended, so that it may become effective at 4:30 p.m., Eastern Time on Monday, August 7, 2023, or as soon thereafter as practicable.
| Very truly yours, | ||
| BENITEC BIOPHARMA INC. | ||
| By: | /s/ Dr. Jerel Banks | |
Name: Dr. Jerel Banks | ||
Title: Chief Executive Officer | ||
